Future research should further explore the specific regulatory mechanisms of Berbamine on TNFAIP3, with the aim of providing novel therapeutic strategies for the co-morbid treatment of COPD and insomnia. This evidence concerns the gene TNFAIP3 and chronic obstructive pulmonary disease.